海王英特龍2023年第三季度報(bào)告

Third Q%5Cuarterly Report 2022第三季度報(bào)告 CHARACTERISTICS OF GEM OF THE STOCK EXCHANGE OF HONG KONG LIMITED (THE “STOCK EXCHANGE”) GEM has been positioned as

CHARACTERISTICS OF GEM OF THE STOCK EXCHANGE OF HONG KONG LIMITED (THE “STOCK EXCHANGE”) GEM has been positioned as a market designed to accommodate s

CHARACTERISTICS OF GEM OF THE STOCK EXCHANGE OF HONG KONG LIMITED (THE “STOCK EXCHANGE”) GEM has been positioned as a market designed to accommodate s

2018 Third Q%5Cuarterly Report 第三季度報(bào)告 CHARACTERISTICS OF GEM OF THE STOCK EXCHANGE OF HONG KONG LIMITED (THE “STOCK EXCHANGE”) GEM has been positioned as

2023 First Q%5Cuarterly Report 第一季度報(bào)告 CHARACTERISTICS OF GEM OF THE STOCK EXCHANGE OF HONG KONG LIMITED (THE “STOCK EXCHANGE”) GEM has been positioned as

CHARACTERISTICS OF GEM OF THE STOCK EXCHANGE OF HONG KONG LIMITED (THE “STOCK EXCHANGE”) GEM has been positioned as a market designed to accommodate s

Third Q%5Cuarterly Report 2017第三季度報(bào)告 2017 香港聯(lián)合交易所有限公司（「聯(lián)交所」）創(chuàng)業(yè)板（「創(chuàng)業(yè)板」）特色 創(chuàng)業(yè)板的定位，乃為相比起其他在聯(lián)交所上市的公司帶有較高投資風(fēng)險(xiǎn)的公司提供一個(gè)上市的市場(chǎng)。有意投資的人士應(yīng)了解投資 於該等公司的潛在風(fēng)險(xiǎn)，並應(yīng)經(jīng)過(guò)審慎周詳?shù)目紤]後

海王英特龍秉持「健康成就未來(lái)」的理念，以現(xiàn)代生物技術(shù)與藥物制劑技術(shù)為創(chuàng)新平臺(tái)，發(fā)展細(xì)胞因子類(lèi)蛋白質(zhì)治療藥物和預(yù)防用生物制品，創(chuàng)建以自主知識(shí)產(chǎn)權(quán)產(chǎn)品研發(fā)和專(zhuān)業(yè)化營(yíng)銷(xiāo)能力為代表的核心競(jìng)爭(zhēng)力，逐步確立國(guó)內(nèi)市

海王英特龍秉持「健康成就未來(lái)」的理念，以現(xiàn)代生物技術(shù)與藥物制劑技術(shù)為創(chuàng)新平臺(tái)，發(fā)展細(xì)胞因子類(lèi)蛋白質(zhì)治

CHARACTERISTICS OF GEM OF THE STOCK EXCHANGE OF HONG KONG LIMITED (THE “STOCK EXCHANGE”) GEM has been positioned as a market designed to accommodate s